Ensure EU GMP Annex 1 compliance before August 2023 deadline
Beckman Coulter Life Sciences offers tailored solutions for EU GMP compliance and beyond
Beckman Coulter Life Sciences offers tailored solutions for EU GMP compliance and beyond
Steve Rees, Vice-President of Screening Sciences and Sample Management, Talks to Kerry Parker
The first patients have been enrolled in this trial to help treatment for Amyotrophic Lateral Sclerosis (ALS)
The development of these potent inhibitors of the CBM signalosome complex, shows promising results by demonstrating apoptosis and tumor growth inhibition
Certification demonstrates that BioEcho Life Sciences quality management system conforms to the standard for medical device and in vitro diagnostic manufacturing
Bath-based digital science publisher visits nearby life sciences supplier following royal reception at Windsor Castle
The integrated technology provides a true system approach to gas chromatography
ICP-MS MassHunter 4.3 Workstation software controls all aspects of the setup and operation of your Agilent ICP-MS and ICP-QQQ instruments and accessories. Compatible with the 7800 and 7900 quadrupole ICP-MS, and 8800/8900 Triple Quadrupole ICP-MS (ICP-QQQ), as well as the previous 7700 Series, ICP-MS MassHunter 4.3 makes running your Agilent ICP-MS system easier than ever.
We manufacture non-coding RNAs and provide tailored synthesis at milligram to multigram scales, with lengths ranging from a few hundred nucleotides to greater than 10 kilobases. TriLink has a large collection of modified nucleotides that can modulate innate immune recognition to maximize activity for your specific application.
The Rigaku ResQ CQL 1064 nm handheld Raman analyzer will be deployed globally as part of the U.S. Dismounted Reconnaissance Sets, Kits, and Outfits (DR SKO) Program
Discover the key strategies and technologies for successful lead optimization in translational medicine, empowering your biotherapeutic antibody development with robust data and de-risking the path to clinical advancement
AEOL 10150 is currently the only drug being developed by BARDA to address the delayed effects of radiation exposure
Trial successfully identifies people with advanced non-small cell lung cancer for treatment with Alecensa
The microplate is specifically designed for labs processing cannabis samples for analysis of tetrahydrocannabinol and cannabidiol
Meet the inflammation and immunity researcher studying the fundamental cellular mechanisms behind uncontrolled inflammatory responses to allergens
Researcher Meritxell Huch awarded the BINDER Innovation Prize